Jun 08, 2020
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $40.90 to $29.21.
The split itself did not change the total investment value.
Zhejiang Shengda Bio-Pharm Co., Ltd. Class A (SSE:603079) operates in the Pharmaceuticals: major industry.
Zhejiang Shengda Bio-Pharm Co., Ltd. Class A company overviewZhejiang Shengda Bio-Pharm Co., Ltd. Class A's most recent stock split was on June 8, 2020. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
Zhejiang Shengda Bio-Pharm Co., Ltd. Class A (SSE:603079) has split its stock 2 times: a 7-for-5 split on June 8, 2018 and a 7-for-5 split on June 8, 2020.
Zhejiang Shengda Bio-Pharm Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between June 8, 2018 and June 8, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Shengda Bio-Pharm Co., Ltd. Class A's 7-for-5 split on June 8, 2020, every 5 shares became 7 shares.
Zhejiang Shengda Bio-Pharm Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 8, 2020, 6 years ago. Companies announce splits in advance, and any new SSE:603079 split will appear on this page.
Already premium?